Literature DB >> 14422065

Long-term use of phenylbutazone in rheumatoid arthritis.

R M MASON, V L STEINBERG.   

Abstract

Entities:  

Keywords:  PHENYLBUTAZONE/therapy

Mesh:

Substances:

Year:  1960        PMID: 14422065      PMCID: PMC2097811          DOI: 10.1136/bmj.2.5202.828

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  Phenylbutazone in rheumatoid arthritis.

Authors:  C J SMYTH; G M CLARK
Journal:  J Chronic Dis       Date:  1957-06

2.  Gastrointestinal intolerance to oral iron preparations.

Authors:  D N KERR; S DAVIDSON
Journal:  Lancet       Date:  1958-09-06       Impact factor: 79.321

3.  The present status of phenylbutazone therapy in rheumatic disease.

Authors:  R M MASON; R R HAYTER
Journal:  Practitioner       Date:  1958-07

4.  Death from hypersensitivity due to phenylbutazone.

Authors:  D J O'BRIEN; G STOREY
Journal:  Br Med J       Date:  1954-04-03

5.  Phenylbutazone; further clinical evaluation.

Authors:  W C KUZELL; R W SCHAFFARZICK; W E NAUGLER; G GAUDIN; E A MANKLE
Journal:  AMA Arch Intern Med       Date:  1953-11

6.  The toxic effects of phenylbutazone (butazolidin); review of the literature and report of the twenty-third death following its use.

Authors:  E F MAUER
Journal:  N Engl J Med       Date:  1955-09-08       Impact factor: 91.245

7.  Untoward effects of phenylbutazone (butazolidin)-a re-evaluation.

Authors:  I L SPERLING
Journal:  Arthritis Rheum       Date:  1959-06
  7 in total
  4 in total

1.  Iragapyrin toxicity.

Authors:  L Ramakumar; B G Goyal
Journal:  Indian J Pediatr       Date:  1967-02       Impact factor: 1.967

Review 2.  Current therapy of rheumatoid arthritis.

Authors:  E J Kamin; C V Multz
Journal:  Calif Med       Date:  1969-01

3.  Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance.

Authors:  M R Fletcher; W Loebl; J T Scott
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

4.  HEMATOLOGICAL COMPLICATIONS OF PHENYLBUTAZONE THERAPY: REVIEW OF THE LITERATURE AND REPORT OF TWO CASES.

Authors:  D D MCCARTHY; T M CHALMERS
Journal:  Can Med Assoc J       Date:  1964-05-02       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.